Form 4: P&G Executive Receives Significant Stock Award
Insider Trading Report
Procter & Gamble's Chief R&D Officer, Moses Victor Javier Aguilar, was granted 15,314 shares of common stock and additional Restricted Stock Units.
Summary
- Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer at Procter & Gamble Co (PG), received a stock award and Restricted Stock Units.
- On August 19, 2025, Mr. Aguilar was granted 15,314 shares of common stock at a price of $0, pursuant to the issuer's 2019 Stock and Incentive Compensation Plan.
- Additionally, on August 15, 2025, Mr. Aguilar acquired 13.1431 Restricted Stock Units (RSUs) as dividend equivalents from the issuer's retirement program.
- The total beneficial ownership of common stock following these transactions is 40,841.1704 directly, 6,750.7456 indirectly through a Retirement Plan Trustee, and 428.6033 indirectly through an International Stock Ownership Plan (Mexico) Trustee.
- The RSUs represent a contingent right to receive Procter & Gamble common stock and will deliver shares upon retirement, unless deferred or contributed to a deferred compensation account.
- The Form 4 was submitted late due to an inadvertent administrative error, not an error by the reporting person.
Sentiment
Score: 7
Explanation: The filing indicates a routine executive compensation event, which is generally positive for aligning management and shareholder interests, despite a minor administrative error in filing timeliness.
Positives
- A significant stock award of 15,314 shares of common stock was granted to a key executive, aligning management's interests with shareholders.
- Additional Restricted Stock Units (RSUs) were granted as dividend equivalents, further increasing the executive's equity stake.
Negatives
- The Form 4 was submitted late due to an administrative error, which could indicate minor internal process inefficiencies.
Future Outlook
The Restricted Stock Units will deliver shares upon the executive's retirement from the company, unless delivery is deferred or contributed to a deferred compensation account.
Management Comments
- The late filing is due to an inadvertent administrative error and not any error of the reporting person.
Industry Context
This filing reflects standard executive compensation practices within large, publicly traded companies, where equity awards are a common component to incentivize long-term performance and align executive interests with shareholder value.
Comparison to Industry Standards
- The use of stock awards and Restricted Stock Units (RSUs) as part of executive compensation is a common practice across major consumer goods companies like Unilever, Kimberly-Clark, and Colgate-Palmolive, aligning executive incentives with company performance and shareholder returns.
- Granting shares at a $0 price for compensation is typical for performance-based or time-vested equity awards, similar to practices seen at companies such as Johnson & Johnson or PepsiCo.
Stakeholder Impact
- Shareholders: The equity grant aligns the executive's financial interests with long-term shareholder value creation.
- Employees: Reflects the company's compensation structure for senior leadership, potentially influencing broader compensation strategies.
Next Steps
- The Restricted Stock Units will convert into shares upon the executive's retirement, unless deferred or contributed to a deferred compensation account.
Key Dates
| Date | Description |
|---|---|
| 08/15/2025 | Date of acquisition of 13.1431 Restricted Stock Units (RSUs) as dividend equivalents. |
| 08/19/2025 | Date of acquisition of 15,314 shares of Common Stock as a stock award. |
| 08/27/2025 | Date the Form 4 was signed by the attorney-in-fact for Mr. Aguilar Moses. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event involving stock awards and Restricted Stock Units. While it aligns executive interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for Procter & Gamble. The minor administrative error in filing timeliness is not material enough to warrant a change in investment stance. Therefore, a 'hold' recommendation is appropriate as the filing confirms ongoing, expected corporate governance and compensation practices without providing catalysts for significant upside or downside.
Keywords
Procter & Gamble, PG, Moses Victor Javier Aguilar, Stock Award, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.